Year : 2010  |  Volume : 13  |  Issue : 3  |  Page : 264-

Post-operative management of endarterectomy


Viroj Wiwanitkit 
 Wiwanitkit House, Bangkhae, Bangkok - 10160, Thailand

Correspondence Address:
Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok - 10160
Thailand




How to cite this article:
Wiwanitkit V. Post-operative management of endarterectomy.Ann Card Anaesth 2010;13:264-264


How to cite this URL:
Wiwanitkit V. Post-operative management of endarterectomy. Ann Card Anaesth [serial online] 2010 [cited 2022 May 25 ];13:264-264
Available from: https://www.annals.in/text.asp?2010/13/3/264/69063


Full Text

The Editor,

I read the recent report on post-operative management of endarterectomy with great interest. [1] Iyengar et al, concluded that "Pulmonary endarterectomy is an effective and potentially curative surgical treatment for patients with severe chronic thromboembolic pulmonary hypertension." [1] Of interest, this alternative approach for the cases unfit for pulmonary thrombectomy might be a good one. However, there are also several factors determining the outcome of chronic thromboembolic pulmonary hypertension, including splenectomy, permanent central intravenous lines and certain inflammatory disorders. [2] .In addition, in the report by Iyengar et al, there are some points of concern. First, the nature of the retrospective study might pose some bias and the numbers of subjects might be a major limitation of the generalization of the results. Additionally, the novel pharmacotherapy that is recommended for chronic thromboembolic pulmonary hypertension, Bosentan, should also be mentioned. [3] The comparison between this medical approach and pulmonary endarterectomy can give useful clinical information.

References

1Narayana Iyengar RM, Hegde D, Gupta R, Patil L. Postoperative management of pulmonary endarterectomy and outcome. Ann Card Anaesth 2010;13:22-7.
2Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 2007;115:2153-8.
3Raja SG, Dreyfus GD. Current status of bosentan for treatment of pulmonary hypertension. Ann Card Anaesth 2008;11:6-14.